Surprise! Biogen goes with commercial chief Vounatsos in replacing CEO Scangos
Biogen is promoting chief commercial officer Michel Vounatsos as its new CEO, replacing outgoing CEO George Scangos and focusing directly on its late-stage pipeline and new deals for future growth.
The Merck vet arrived at Biogen last March to oversee the company’s global commercial strategy. The French native stayed at Merck for 20 years, rising to president of the company’s primary care business line.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.